Operational Utility

• Viz LVO: The moment a CTA is completed, the AI analyzes it. If a Large Vessel Occlusion is found, it bypasses the radiologist's worklist and alerts the Neurosurgeon directly. This reduces "Door-to-Needle" time by an average of 40-60 minutes.
• Viz ICH & SDH: Automates the tedious measurement of bleed volumes. It calculates the volume automatically, which is critical for deciding transfer eligibility (e.g., "Is this bleed big enough to need surgery?").
• Viz Aneurysm: Acts as a "Safety Net" for incidental findings. It flags unruptured aneurysms that might be missed on a trauma scan, creating a dedicated outpatient follow-up list for the neuro clinic (Revenue Driver).
• Viz Assist: The platform has moved beyond just images. Viz Assist is an "Agentic AI" that ingests the EMS notes and ER physician notes to draft a pre-chart summary, giving the neurosurgeon context ("Last known normal: 2 hours ago") alongside the images.

The "Trust" Profile (Compliance & Security)

• HIPAA Compliant: Yes.
• FDA Status: Cleared (510k / De Novo).
  Neuro Portfolio: Holds clearances for LVO (Stroke), ICH (Bleed), Aneurysm, and Subdural Hematoma (SDH) quantification.
• Certifications: SOC 2 Type II and ISO 27001:2022.
• Cybersecurity: Because it sits inside the hospital firewall to intercept DICOM images, Viz uses a "Zero Trust" architecture that is heavily vetted by DoD and VA hospital security teams.

Implementation & Integrations

• Network Effect: Viz.ai is most powerful when installed across a region. A community hospital ("Spoke") can instantly share high-fidelity images with the tertiary center ("Hub") via the app, allowing the expert to say "Ship them now" or "Keep them there" in seconds.
• EHR Integration: Deep, bi-directional sync with Epic and Cerner.
  • Value: It pulls patient demographics so the mobile alert has the real patient name/DOB, not just "Unknown Male."
• PACS Integration: It sends the AI-annotated images (with the clot circled) back into the PACS (e.g., Sectra, Visage) as a secondary capture for the radiologist’s permanent record.

Pricing Model

• Structure: Annual Enterprise License.
• Cost: Viz.ai does not publish public pricing. Users must contact sales for a custom quote based on claim volume.
• Estimated Cost: ~$50k – $250k+ per year (varies by bed count and module).
• Source: Market reports (e.g., Forbes 2023) indicate pricing scales from $50k for small centers to $1M+ for large health networks.
• Reimbursement Reality:
  • The NTAP Shift: The famous "New Technology Add-on Payment" (NTAP) for stroke AI has largely sunsetted. You can no longer rely on the government paying you ~$1,000 extra per case just for using Viz.
  • The New ROI: The ROI is now purely Operational Volume. Viz.ai pays for itself by increasing the number of Thrombectomies performed (by catching missed clots) and Aneurysm Coiling procedures (by catching incidental findings).

The Doxiverse Assessment: Risks & Limitations

• The Strategic Upside: Recruiting Tool. Neurointerventionalists expect to have Viz.ai on their phones. Not having it puts a hospital at a disadvantage when recruiting top stroke talent.
• The Downside: Viz alerts the surgeon before the radiologist reads the scan. If a surgeon books an OR based on the AI, only for the radiologist to later call it a "False Positive."
• False Positives: While excellent, the AI is not perfect. It can mistake "vessel calcification" for a clot.

Ideal User Profile

• Perfect For: Comprehensive & Primary Stroke Centers managing high transfer volumes.
• Not For: Outpatient Imaging Centers (OIC) or small rural clinics with no transfer pathway.

Part of the Viz.ai Clinical Suite

This profile covers the Neurovascular modules.

🔗 See also:
Viz.ai (Vascular & Cardio) – For PE, Aortic, and HCM triage.
Viz.ai (Radiology)
Viz Assist (The "Scribe")